Vivimed Labs Ltd Share Price NSE India S.E.
Equities
INE526G01013
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- INR | - |
02-26 | Vivimed Labs CFO Resigns | MT |
02-24 | Vivimed Labs Limited Announces Resignation of Ramakanta Tripathy as Chief Financial Officer | CI |
Sales 2022 | 2.39B 28.62M 2.28B | Sales 2023 | 1.88B 22.56M 1.8B | Capitalization | 547M 6.57M 523M |
---|---|---|---|---|---|
Net income 2022 | -677M -8.12M -647M | Net income 2023 | -3.28B -39.41M -3.14B | EV / Sales 2022 | 1.98 x |
Net Debt 2022 | 3.52B 42.19M 3.36B | Net Debt 2023 | 3.77B 45.26M 3.61B | EV / Sales 2023 | 2.3 x |
P/E ratio 2022 |
-1.78
x | P/E ratio 2023 |
-0.17
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.35% |
Managers | Title | Age | Since |
---|---|---|---|
Santosh Varalwar
CEO | Chief Executive Officer | 62 | 08/11/89 |
Compliance Officer | - | - | |
S. G. Saurabh
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Santosh Varalwar
CEO | Chief Executive Officer | 62 | 08/11/89 |
Sandeep Varalwar
BRD | Director/Board Member | 55 | 22/01/08 |
Subhash Varalwar
BRD | Director/Board Member | 76 | 08/11/89 |
1st Jan change | Capi. | |
---|---|---|
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |